Medindia LOGIN REGISTER
Medindia
Muscle Atrophy

Muscle Atrophy


References:

  1. Vinciguerra M, Musaro A, Rosenthal N. Regulation of muscle atrophy in aging and disease. Adv Exp Med Biol. 2010;694:211-33.
  2. Naomi E. Brooks and Kathryn H. Myburgh (2012). Prevention of Skeletal Muscle Wasting: Disuse Atrophy and Sarcopenia, Skeletal Muscle - From Myogenesis to Clinical Relations, Dr. Julianna Cseri (Ed.), InTech, DOI: 10.5772/47856.
  3. Jackman RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. American Journal of Physiology - Cell Physiology. 2004;287(4):C834-C843.
  4. Bonaldo P, Sandri M. Cellular and molecular mechanisms of muscle atrophy. Disease Models & Mechanisms. 2013;6(1):25-39.
  5. Brooks N, Myburgh K. Skeletal muscle wasting with disuse atrophy ismulti-dimensional: the response and interaction of myonuclei, satellite cells and is signaling pathways. Frontiers in Physiology. 2014;5(99).
  6. Theodorou DJ, Theodorou SJ, Kakitsubata Y. Skeletal muscle disease: patterns of MRI appearances. The British Journal of Radiology. 2012;85(1020):e1298-e1308. doi:10.1259/bjr/14063641.
  7. Wadman RI, Bosboom WMJ, van der Pol WL, van den Berg LH, Wokke JHJ, Iannaccone ST, Vrancken AFJE. Drug treatment for spinal muscular atrophy type I. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD006281. DOI: 10.1002/14651858.CD006281.pub4.
  8. Wadman RI, Bosboom WMJ, van der Pol WL, van den Berg LH, Wokke JHJ, Iannaccone ST, Vrancken AFJE. Drug treatment for spinal muscular atrophy types II and III. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD006282. DOI: 10.1002/14651858.CD006282.pub4
  9. van Alfen N, van Engelen BGM, Hughes RAC. Treatment for idiopathic and hereditary neuralgic amyotrophy (brachial neuritis). Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD006976. DOI: 10.1002/14651858.CD006976.pub2.
  10. Voet NBM, van der Kooi EL, Riphagen II, Lindeman E, van Engelen BGM, Geurts ACH. Strength training and aerobic exercise training for muscle disease. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD003907. DOI: 10.1002/14651858.CD003907.pub4.
  11. Marimuthu, K., Murton, A. J., and Greenhaff, P. L. (2011). Mechanisms regulating muscle mass during disuse atrophy and rehabilitation in humans. J. Appl. Physiol. 110, 555–560. doi: 10.1152/japplphysiol.00962.2010
  12. Resistance Training (Strength Training) - (https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0022361/)
  13. Atrophy - (https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0024970/)
  14. What is Muscle atrophy? - (https://medlineplus.gov/ency/article/003188.htm)
  15. Muscle Atrophy (Muscle Wasting) - (https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0024971/)
  16. Muscular dystrophy - (https://medlineplus.gov/ency/article/001190.htm)
  17. Amyotrophic lateral sclerosis (ALS) - (https://medlineplus.gov/ency/article/000688.htm)
Author: Dr. Smitha S. Dutt

Editor: Dr. Simi Paknikar

Technically Checked by: Lingaraj
Advertisement